2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Torres-Jurado, MJ, Gómez-Hernández, MT, Valera-Montiel, AE, Vicente-González, L, Abdel-Lah-Fernández, O, Parreño-Manchado, FC, Jiménez-López, MF. Non-hiatal diaphragmatic hernias: results of transabdominal and transthoracic surgical approaches at a fourth-level hospital. HERNIA 28 1747-1754. 1 oct 2024. 1 may 2024. . F.I.:2,600 [doi:10.1007/s10029-024-03065-1]
de la Fuente, A, López-Sánchez, J, Vaquero-Roncero, LM, García, MM, Barrado, MES, Sánchez-Hernandez, MV, García-Mateo, N, Rico-Feijoo, J, Muñoz-Bellvís, L, de Castro, RG, Tedim, AP, Ortega, A, Fernandez, OAL, Suárez-de-la-Rica, A, Maseda, E, González, IT, Carrera, GLG, Marcos-Vidal, JM, Arranz, JMN, Chiscano-Camón, L, Ferrer, R, Ruiz-Rodríguez, JC, González-López, JJ, Fernández, JAV, Carballo, RP, Lopez-Izquierdo, R, Garrosa, S, Barón, B, Esteban-Velasco, C, Aldecoa, C, Bermejo-Martin, JF. Synergistic impact of innate immunity hyper-activation and endothelial dysfunction on the magnitude of organ failure in the infection-sepsis continuum. INT J INFECT DIS 146 -. 1 sep 2024. 1 jul 2024. . F.I.:4,800 [doi:10.1016/j.ijid.2024.107142]
Eguía-Larrea, M, Parra-Pérez, C, Cabero-Morán, T, Rosellón, RJ, Muñoz-Bellvís, L. Triple negative breast cancer, androgen receptor and other markers. Therapeutic strategies. REV SENOL PATOL MAM 37 -. 1 jul 2024. 1 abr 2024. . F.I.: [doi:10.1016/j.senol.2024.100595]
de la Fuente, A, Postigo, T, Ferri, FS, Domínguez-Gil, M, alvarez-Manzanares, J, Eiros, JM, Rodríguez, VC, Ramon, SS, Ortega, A, Millán, LNF, Vaquero-Roncero, LM, Esteban-Velasco, C, Navarro-Matías, E, Barbé, F, Bermejo-Martin, JF, Lopez-Izquierdo, R. Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19. INT J INFECT DIS 140 132-135. 1 mar 2024. 1 feb 2024. . F.I.:4,800 [doi:10.1016/j.ijid.2024.01.018]

Torres-Jurado, MJ, López-Sánchez, J, Quiñones-Sampedro, JE, Muñoz-Bellvís, L. Percutaneous cholecystostomy: an unusual route of dissemination of gallbladder carcinoma. REV ESP ENFERM DIG 116 171-172. 1 ene 2024. . . F.I.:2,700 [doi:10.17235/reed.2023.9646/2023]